BEAM:BMV
Beam Therapeutics Inc
453,00 MXN
arrow_upward
+1,67%(+7,43) 1D
8-окт., 07:30:20 GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Mkt. cap
2,60 млд
Avg. vol.
13,00
Volume
0,00
52-wk high
663,44 MXN
52-wk low
384,79 MXN
No. of employees
540
Mkt. cap
2,60 млд
Avg. vol.
13,00
Volume
0,00
52-wk high
663,44 MXN
52-wk low
384,79 MXN
No. of employees
540
News stories
From web sources and news partners
CNBC
·
1 саат мурун
Jim Cramer says the bull market's remarkable 4-year run offers a crucial lesson for investors
New York Post
·
1 саат мурун
NYSE's opening bell honors Italian Americans who beat stereotypes to reach pinnacle of finance
Simply Wall Street
·
20 мүнөт мурун
What Does Microsoft (MSFT) Gain From Its New Maia 300 AI Chip?
Reuters
·
12 мүнөт мурун
Nasdaq ends lower as oil prices surge ahead of earnings, economic data
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc